Edward R. Teitel
Plus aucun poste en cours
Profil
Edward R.
Teitel is the founder of AggreDyne, Inc. (2011) and ThromboVision, Inc. (2005), where he held the title of President & Chief Executive Officer.
He also held former positions as Chairman at Vaneltix Pharma, Inc. (2010-2011) and Chief Medical Officer at MicroMed Technology, Inc. Dr. Teitel's education history includes an MBA from Auburn University, an undergraduate degree from Sul Ross State University, a graduate degree from the University of Houston, and a doctorate and another graduate degree from Texas University of Health Center at San Antonio.
Anciens postes connus de Edward R. Teitel
| Sociétés | Poste | Fin |
|---|---|---|
Vaneltix Pharma, Inc.
 Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Président | 28/10/2011 |
Aggredyne, Inc.
 Aggredyne, Inc. Electronic Equipment/InstrumentsElectronic Technology Aggredyne, Inc. develops laser light scattering platelet aggregometer that provides a full profile of a patient’s responsiveness to their anti-platelet medications. The company was founded by Edward R. Teitel and Robert C. Hux in 2011 and is headquartered in Houston, TX. | Fondateur | - |
ThromboVision, Inc.
 ThromboVision, Inc. Medical SpecialtiesHealth Technology ThromboVision, Inc. develops diagnostics products. It is a biomedical company which enables people to lead longer and healthier lives. The firm provides easy-to-use, rapid-response and versatile clinical diagnostic discoveries that advance medical diagnosis. The company was founded by Kenneth A. Solen, Edward R. Teitel and Sivaprasad Sukavaneshvar in 2005 and is headquartered in Houston, TX. | Fondateur | - |
MicroMed Technology, Inc.
 MicroMed Technology, Inc. Electronic Equipment/InstrumentsElectronic Technology MicroMed Technology, Inc. used to develop medical products for patients with end-stage and congestive heart failure (CHF). The company was located in Houston, TX. | Directeur Technique/Scientifique/R&D | - |
Formation de Edward R. Teitel
| Auburn University | Masters Business Admin |
| Sul Ross State University | Undergraduate Degree |
| University of Houston | Graduate Degree |
| Texas University of Health Center at San Antonio | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
MicroMed Technology, Inc.
MicroMed Technology, Inc. Electronic Equipment/InstrumentsElectronic Technology MicroMed Technology, Inc. used to develop medical products for patients with end-stage and congestive heart failure (CHF). The company was located in Houston, TX. | Electronic Technology |
ThromboVision, Inc.
ThromboVision, Inc. Medical SpecialtiesHealth Technology ThromboVision, Inc. develops diagnostics products. It is a biomedical company which enables people to lead longer and healthier lives. The firm provides easy-to-use, rapid-response and versatile clinical diagnostic discoveries that advance medical diagnosis. The company was founded by Kenneth A. Solen, Edward R. Teitel and Sivaprasad Sukavaneshvar in 2005 and is headquartered in Houston, TX. | Health Technology |
Aggredyne, Inc.
Aggredyne, Inc. Electronic Equipment/InstrumentsElectronic Technology Aggredyne, Inc. develops laser light scattering platelet aggregometer that provides a full profile of a patient’s responsiveness to their anti-platelet medications. The company was founded by Edward R. Teitel and Robert C. Hux in 2011 and is headquartered in Houston, TX. | Electronic Technology |
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Health Technology |
